Skip to content
Search

Latest Stories

Zydus Cadila gets USFDA nod for generic cancer drug

Zydus Cadila gets USFDA nod for generic cancer drug
Shilpa Sharma
By Shilpa SharmaJun 25, 2021
Shilpa Sharma
See Full Bio

DRUG maker Zydus Cadila today (25) received an approval from the US health regulator to market Pemetrexed injection in the American market.

Pemetrexed is used to treat certain kinds of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that helps in slowing or stopping the growth of cancer cells.

The firm got nod from the US Food and Drug Administration (USFDA) for the injection in the strengths of 100mg/vial, 500 mg/vial, and 1000 mg/vial, single-dose vials, it said in a statement.

The approved drug will be produced at the formulation manufacturing facility at Ahmedabad in India, the company said.

Zydus Cadila now has 319 approvals.

Since 2003-04, the company has filed over 400 abbreviated new drug applications (ANDAs).

The company discovers, develops, manufactures, and markets a broad range of healthcare products. The group employs around 25,000 people worldwide.

usindia
Add EasternEye As Your Trusted Source
preferred source on google news

Related News

Sanjay Bhandari's extradition appeal opens in London
Business

Sanjay Bhandari's extradition appeal opens in London

Rupert Murdoch looks on as he walks on the day of the hearing on the contentious matter of succession of Rupert Murdoch's global television and publishing empire, in Reno, Nevada, US, September 23, 2024. (Photo: Reuters)
Business

Murdoch's bid to secure eldest son's control of media empire fails

Kamlesh Pattni faces UK sanctions for illicit gold trade
Business

Kamlesh Pattni faces UK sanctions for illicit gold trade

Sanjay Malhotra speaks during the 67th Foundation Day of the Directorate of Revenue Intelligence (DRI) in New Delhi on December 4, 2024. (Photo: Getty Images)
Business

India appoints Sanjay Malhotra as new central bank governor

EasternEye

More For You

Google Health

Google is focusing on fixing everyday health tracking issues in its latest app update

iStock

Google Health moves to fix post-redesign headaches with major update

  • Google Health 5.01 introduces 16 fixes and improvements across the app.
  • Users can now log previously created custom foods and track workouts more accurately.
  • Sleep scores, step counting and third-party app integrations have all been updated.

Google has started rolling out the first major update to its redesigned Google Health app, introducing a series of fixes aimed at improving the accuracy of health data and smoothing out some of the frustrations reported by users since the overhaul launched.

The Google Health 5.01 update includes 16 changes covering nutrition tracking, fitness monitoring, sleep data and general app performance. While Google has issued smaller patches in recent weeks, this marks the first significant update since the redesign and appears to focus largely on improving reliability rather than adding major new features.

Keep ReadingShow less